At the transcriptional level, senescence markers, viz., p53, p21, p16, and β-galactosidase 1 (GLB1), were significantly (p < 0.05) elevated in patients with type 2 diabetes compared to control subjects (Fig. 3a). This evidence concerns the gene CDKN2A and type 2 diabetes mellitus.